Cumberland Pharmaceuticals (CPIX) Interest Expenses (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Interest Expenses across 17 years of filings, most recently posting $85839.0 for Q1 2026.

• Interest Expenses for Q1 2026 came in at $85839.0, down 47.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $418027.0 (down 35.77% YoY), and the FY2025 annual result was $495990.0, down 18.09% from the prior year.
• Interest Expenses came in at $85839.0 for Q1 2026 at Cumberland Pharmaceuticals, down from $112942.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $223261.0 in Q4 2024 to a low of $85839.0 in Q1 2026.
• The 5-year median for Interest Expenses is $137374.0 (2024), against an average of $143599.6.
• Across the five-year window, Interest Expenses jumped 645.92% in 2022 and sank 49.41% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Interest Expenses stood at $179456.0 in 2022, then retreated by 0.37% to $178792.0 in 2023, then grew by 24.87% to $223261.0 in 2024, then slumped by 49.41% to $112942.0 in 2025, then declined by 24.0% to $85839.0 in 2026.
• The last three Interest Expenses figures came in at $85839.0 (Q1 2026), $112942.0 (Q4 2025), and $109699.0 (Q3 2025), per Business Quant data.